Revelation Biosciences Inc.
Harnessing the power of trained immunity
Harnessing the power of trained immunity
Revelation Biosciences Inc. is a biotechnology and health care startup founded in 2020. With the slogan "Using cutting edge science to develop innovative therapeutics and diagnostics," the company is focused on developing immunologic therapeutics and diagnostics to advance global health. Based in the United States, the startup recently secured a noteworthy investment of $6.20M in post-IPO equity at 01 February 2024. This significant investment reflects confidence in the company's mission and potential for growth within the biotechnology and health care industries. As Revelation Biosciences continues to leverage its cutting-edge science to develop groundbreaking solutions, it stands poised to make a meaningful impact on the world's health and well-being.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | $6.20M | - | 01 Feb 2024 | |
| Post-IPO Equity | $15.60M | - | 09 Feb 2023 | |
| Post-IPO Equity | $5.00M | - | 26 Jul 2022 | |
| Post-IPO Equity | $7.76M | - | 24 Jan 2022 | |
| Convertible Note | $2.50M | 1 |
|
21 Dec 2021 |
We care about your data, and we'd love to use cookies make your experience better.
